The new infliximab point-of-care quantitative test can equally be used for therapeutic drug monitoring of biosimilars of infliximab

October 10, 2017

Quantum Blue^® Infliximab Citation:

J. Afonso, H.T. Sousa, I.Rosa, J.Carvalho, C. C. Dias, F. Magro on behalf GEDII